查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750638

全球細胞培養維生素市場規模、佔有率、趨勢分析報告：按產品、最終用途、地區和細分市場預測（2025-2030 年）

Cell Culture Vitamins Market Size, Share & Trends Analysis Report By Product, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

細胞培養維生素市場的成長與趨勢：

根據 Grand View Research, Inc. 的一份新報告，全球細胞培養維生素市場預計到 2030 年將達到 3.43 億美元，2025 年至 2030 年的複合年成長率為 5.6%。

由於各個領域，尤其是生物製藥研發領域對細胞培養技術的依賴日益增加，該市場正在經歷顯著成長。

推動細胞培養維生素市場成長的主要因素之一是生物技術和製藥領域研發投入的大幅增加。各國政府、私人組織和學術機構正在加大對創新藥物研發、疫苗研究以及基因和細胞治療等先進治療技術的投入。

新冠疫情對細胞培養維生素市場產生了重大影響。疫苗和生技藥品的迫切需求加速了對高品質、可擴展的含維生素細胞培養補充劑的需求。這些補充劑對於確保快速穩定生產、支持研究以及實現高效的生產流程以滿足全球疫苗需求至關重要。需求的激增凸顯了細胞培養基配方在疫苗和治療方法開發中的重要性。因此，疫情不僅加劇了對細胞培養維生素的迫切需求，也凸顯了細胞培養維生素在生物製藥製造中的關鍵作用，從而增強了市場的成長軌跡。

癌症、糖尿病和自體免疫疾病等慢性疾病的發生率不斷上升，顯著增加了對更先進、更有針對性的醫療保健解決方案的需求。由於傳統治療方法通常無法解決複雜且長期的病症，人們開始轉向創新的生技藥品和細胞治療方法能夠提供更個人化、更有效的治療方案。這些先進的治療方法在很大程度上依賴細胞培養技術，而維持健康、功能正常的細胞對於成功至關重要。為此，精確控制、營養豐富的培養環境至關重要，尤其是富含維生素的培養環境，這些維生素能夠支持細胞生長、分化和免疫反應。

細胞培養維生素市場報告重點

  • 根據產品，B 群維生素部分將在 2024 年佔據最大的收入佔有率，為 39.12%。市場受到生物製藥製造和研究應用對高品質細胞培養基日益成長的需求的推動。
  • 根據最終用途，細胞培養基製造商部門將主導市場，佔據 2024 年最大的收益佔有率。生物製藥公司和研究中心對優質富含維生素的培養基的需求日益成長，這對於生技藥品、疫苗和細胞療法的大規模生產至關重要，這推動了這一細分市場的擴張。
  • 2024年，北美佔最大佔有率，達37.49%。北美在生物技術、醫療保健和藥物開發領域處於領先地位，因此對細胞培養維生素的需求很高。該地區擁有頂尖的研究中心和公司，致力於開發疫苗、抗體療法和細胞療法，這些都需要高品質、富含維生素的培養基來高效培養細胞。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章細胞培養維生素市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 細胞培養維生素市場的分析工具
    • 波特的分析
    • PESTEL分析
    • COVID-19影響分析

第4章細胞培養維生素市場：產品評估與趨勢分析

  • 產品細分儀表板
  • 全球細胞培養維生素市場：產品差異分析
  • 2018-2030年全球細胞培養維生素市場規模及產品趨勢分析
  • B群維生素
    • 維生素 B 複合物市場規模、預測和趨勢分析（2018-2030 年）
  • 維生素A
    • 維生素 A 市場規模、預測與趨勢分析（2018-2030 年）
  • 維生素C
    • 維生素 C 市場規模、預測與趨勢分析（2018-2030 年）
  • 其他維生素
    • 其他維生素市場規模、預測和趨勢分析（2018-2030 年）

第5章細胞培養維生素市場：最終用途估計與趨勢分析

  • 最終用途細分儀表板
  • 全球細胞培養維生素市場：最終用途差異分析
  • 2018-2030 年全球細胞培養維生素市場規模及最終用途趨勢分析
  • 細胞培養基製造商
    • 細胞培養基製造商的市場規模、預測與趨勢分析（2018-2030年）
  • 製藥和生物技術公司
    • 製藥和生物技術公司的市場規模、預測和趨勢分析（2018-2030 年）
  • CDMO/CMO和CRO
    • CDMO/CMO 和 CRO 市場規模、預測和趨勢分析（2018-2030 年）

第6章細胞培養維生素市場：區域估計和趨勢分析

  • 2024 年及 2030 年各地區市場佔有率分析
  • 區域市場儀表板
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • DSM-Firmenich
    • Merck KGaA
    • Thermo Fisher Scientific
    • FUJIFILM Irvine Scientific
    • Lonza
    • HiMedia Laboratories
    • Danaher
    • Sartorius AG
    • Corning Inc.
    • R&D Systems（Bio-Techne）
Product Code: GVR-4-68040-585-3

Cell Culture Vitamins Market Growth & Trends:

The global cell culture vitamins market size is expected to reach USD 343.0 million by 2030 and is expected to grow at 5.6% CAGR from 2025 to 2030, according to a new report by Grand View Research, Inc. The market has experienced considerable growth as there is an increase in reliance on cell culture technologies across various sectors, particularly in biopharmaceutical research and development

One of the key drivers propelling the growth of the cell culture vitamins market is the significant rise in research and development (R&D) investments across the biotechnology and pharmaceutical sectors. Governments, private organizations, and academic institutions increasingly allocate funds to support innovative drug development, vaccine research, and advanced therapeutic techniques such as gene and cell therapies.

The COVID-19 pandemic has had a profound impact on the cell culture vitamins market. The urgent need for vaccines and biologics accelerated demand for high-quality, scalable cell culture supplements, including vitamins, which are critical in ensuring rapid and consistent production, supporting research, and enabling efficient manufacturing processes to meet global vaccine demand. This surge in demand underscored the importance of cell culture media formulations in vaccine and therapeutic development. Consequently, the pandemic not only amplified the immediate need for cell culture vitamins but also highlighted their essential role in biopharmaceutical manufacturing, thereby reinforcing the market's growth trajectory

The rising prevalence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, has significantly increased the demand for more advanced and targeted healthcare solutions. As traditional treatments often fall short in addressing complex and long-term conditions, there is a growing shift toward innovative biologics and cell-based therapies that offer more personalized and effective approaches. These advanced therapies rely heavily on cell culture technologies, where maintaining healthy and functional cells is critical for success. To achieve this, precisely controlled, nutrient-rich culture environments become essential, particularly those enriched with vitamins that support cell growth, differentiation, and immune response.

Cell Culture Vitamins Market Report Highlights:

  • Based on product, the vitamin B complex segment accounted for the largest revenue share of 39.12% in 2024. The market is driven by increasing demand for high-quality cell culture media in biopharmaceutical manufacturing and research applications.
  • Based on end use, the cell culture media manufacturers segment dominated the market and accounted for the largest revenue share in 2024. Growing needs from biopharmaceutical firms and research centers for premium, vitamin-rich culture media, essential for mass production of biologics, vaccines, and cell therapies, are fueling this market segment's expansion.
  • North America held the largest share of 37.49% in 2024. North America has a high demand for cell culture vitamins because it leads in biotechnology, medicine, and drug development. The region is home to top research centers and companies that create vaccines, antibody treatments, and cell therapies, all of which need high-quality, vitamin-rich culture media to grow cells effectively.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Cell Culture Vitamins Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising demand for biopharmaceuticals
      • 3.2.1.2. Growing investment in R&D
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Stringent regulatory requirements
  • 3.3. Cell Culture Vitamins Market Analysis Tools
    • 3.3.1. Porter's Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Cell Culture Vitamins Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Cell Culture Vitamins Market Product Movement Analysis
  • 4.3. Global Cell Culture Vitamins Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Cell Culture Vitamins
    • 4.4.1. Cell Culture Vitamins Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5. Cell Culture Vitamins
    • 4.5.1. Cell Culture Vitamins Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 5. Cell Culture Vitamins Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Segment Dashboard
  • 5.2. Global Cell Culture Vitamins Market End Use Movement Analysis
  • 5.3. Global Cell Culture Vitamins Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Cell Culture Media Manufacturers
    • 5.4.1. Cell Culture Media Manufacturers Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.5. Pharmaceutical & Biotechnology Companies
    • 5.5.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.6. CDMOs/ CMOs & CROs
    • 5.6.1. CDMOs/ CMOs & CROs Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 6. Cell Culture Vitamins Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. DSM-Firmenich
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Merck KGaA
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Thermo Fisher Scientific
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. FUJIFILM Irvine Scientific
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Lonza
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. HiMedia Laboratories
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Danaher
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Sartorius AG
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Corning Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. R&D Systems (Bio-Techne)
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global cell culture vitamins market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America cell culture vitamins market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 7 North America cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Mexico cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico cell culture vitamins market, by end-use, 2018 - 2030 (USD Million))
  • Table 14 Europe cell culture vitamins market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 16 Europe cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 18 UK cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Germany cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 France cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 22 France cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Italy cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 24 Italy cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Spain cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 26 Spain cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Denmark cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 28 Denmark cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Sweden cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 30 Sweden cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Norway cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 32 Norway cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific cell culture vitamins market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Japan cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 37 Japan cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 China cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 39 China cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 India cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 41 India cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Australia cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 43 Australia cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 South Korea cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 45 South Korea cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Thailand cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 47 Thailand cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Latin America cell culture vitamins market, by country, 2018 - 2030 (USD Million)
  • Table 49 Latin America cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 50 Latin America cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Brazil cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 52 Brazil cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 54 Argentina cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 MEA cell culture vitamins market, by country, 2018 - 2030 (USD Million)
  • Table 56 MEA cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 57 MEA cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 South Africa cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 59 South Africa cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 UAE cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 63 UAE cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 65 Kuwait cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Cell culture vitamins market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Cell culture vitamins market: Product outlook key takeaways
  • Fig. 20 Cell culture vitamins market: Product movement analysis
  • Fig. 21 Vitamin B complex market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Vitamin A market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Vitamin C market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Other vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Cell culture vitamins market: End-use outlook key takeaways
  • Fig. 26 Cell culture vitamins market: End-use movement analysis
  • Fig. 27 Cell culture media manufacturers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 CDMOs/ CMOs & CROs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Regional marketplace outlook, 2024 & 2030 (USD million)
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 North America Cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 U.S. cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Canada cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Mexico cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Europe cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 France cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Spain cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Denmark cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Sweden cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Norway cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Japan cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 China cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 India cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Market participant categorization
  • Fig. 71 Cell culture vitamins market position analysis, 2024
  • Fig. 72 Strategic framework